Largest biotech companies by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech companies ranked by total liabilities, at ¥13.06T, ahead of Gilead Sciences (¥5.8T) and Biogen (¥1.78T). Figures as of 18 Nov 2026, 19:49 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Amgen¥13.06T
Median
¥112.1B
Combined market value
¥133.37T
Countries
5

Market values as of .

All countries
All sectors
Biotech
JPY
Clear filters
Largest biotech companies by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care¥13.06T¥38.22T¥70,665.11 3.18% down 34% up United States
2Gilead SciencesGILD · Health Care¥5.8T¥33.39T¥26,921.60 0.80% down 33% up United States
3BiogenBIIB · Health Care¥1.78T¥5.89T¥39,851.23 0.31% down 49% up United States
4ModernaMRNA · Health Care¥587.8B¥12.78T¥31,584.13 4.18% down 755% up United States
5BioNTechBNTX · Health Care¥488.9B¥3.3T¥13,305.79 1.63% down 16% down Germany
6QiagenQGEN · Health Care¥399B¥1.63T¥7,904.90 0.31% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health Care¥394.7B¥1.75T¥15,323.71 0.18% up 37% up United States
8Neurocrine BiosciencesNBIX · Health Care¥219.7B¥2.64T¥26,039.38 1.54% down 20% up United States
9argenxARGX · Health Care¥216.7B¥9.46T¥150,377.15 0.43% down 4% up Belgium
10ImmunityBioIBRX · Health Care¥159.6B¥1.15T¥1,076.67 7.91% up 193% up United States
11RepligenRGEN · Health Care¥134.5B¥1.75T¥27,307.32 5.64% up 5% up United States
12Revolution MedicinesRVMD · Health Care¥115.3B¥5.53T¥25,564.40 1.41% down 131% up United States
13ExelixisEXEL · Health Care¥108.9B¥2.67T¥10,927.71 0.09% up 63% up United States
14Bio-TechneTECH · Health Care¥76.3B¥1.82T¥11,600.33 0.21% up 26% up United States
15CRISPR TherapeuticsCRSP · Health Care¥54.7B¥629.3B¥6,487.13 1.37% up 21% down Switzerland
16VaxcytePCVX · Health Care¥50.6B¥1.48T¥9,322.66 1.53% down 22% up United States
17Adaptive BiotechnologiesADPT · Health Care¥45.9B¥732B¥4,521.87 0.42% down 88% up United States
18Kodiak SciencesKOD · Health Care¥30.9B¥1.01T¥15,417.70 0.07% down 396% up United States
19Twist BioscienceTWST · Health Care¥26.9B¥1.27T¥18,602.29 4.21% up 340% up United States
20Kymera TherapeuticsKYMR · Health Care¥26B¥1.65T¥19,305.99 0.33% down 87% up United States
21Scholar Rock HoldingSRRK · Health Care¥25.3B¥923.5B¥7,569.38 5.35% up 14% up United States
22Krystal BiotechKRYS · Health Care¥18.2B¥1.48T¥50,014.67 5.10% up 46% up United States
23ImmunovantIMVT · Health Care¥16.6B¥1.1T¥5,291.71 0.03% down 43% up United States
24CG OncologyCGON · Health Care¥6.2B¥1.14T¥12,787.78 1.63% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 159.4 JPY).

Questions and answers

Which biotech companies rank first by total liabilities?

Amgen (¥13.06T), Gilead Sciences (¥5.8T) and Biogen (¥1.78T) are the top three of the 24 biotech companies ranked by total liabilities as of 18 Nov 2026, 19:49 UTC.

How many biotech companies are in this ranking?

24 are ranked by total liabilities.

What are these biotech companies worth together?

The 24 biotech companies ranked by total liabilities have a combined market value of ¥133.37T as of 18 Nov 2026, 19:49 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.